OpenStreetMap (new tab)

Google Map (new tab)

Google Streetview (new tab)

The Danish pharmaceutical company Novo Nordisk A/S opened its Seattle inflammatory diseases research center in 2009. In 2012, it added 10-12 new employees to staff a diabetes research lab; this complemented its existing workforce of 71. (See Erin Flemming, "Novo Nordisk steps up research on diabetes," Seattle Times, 05/04/2012, p. A10, A12.) A press release prepared by the company in 2009 stated: "Novo Nordisk announced its plans to create a new research centre in Seattle in August 2008 and has assembled a highly skilled management team led by Don Foster, vice president of inflammation. It is planned that the centre will have a total of 60 employees by the end of 2010. Research activities in Seattle will complement continuing biopharmaceutical research activities in Novo Nordisk’s research sites in Måløv in Denmark and Beijing in China." (See "Novo Nordisk opens new research centre in Seattle [18 September 2009]"Accessed 05/04/2012.) Tel: 206.490.5700 (2012).

PCAD id: 17838